Medinex Ltd. (OTX) AI Stock Analysis

• Market Cap: S$30.95M
• Dividend Yield: 7.3%
• Average Volume (3M): 102.58K
• Price to Earnings (P/E): 13.1
• Beta (1Y): 0.14
• Revenue Growth: -3.11%
• EPS Growth: -21.50%
• Country: SG
• Employees: 73
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 0.02
• Shares Outstanding: 134,543,840
• 10 Day Avg. Volume: 45,910
• 30 Day Avg. Volume: 102,580
• PEG Ratio: -0.61
• Price to Book (P/B): 1.82
• Price to Sales (P/S): 2.42
• P/FCF Ratio: 11.76
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: S$0.25 ▲(3.33% Upside)
• Action: Reiterated
• Date: 07/01/26

Positive Factors

Very high gross margins

Sustained gross margins near 73%–80% indicate durable product/service economics and pricing power versus peers. High gross margins create a persistent buffer for operating leverage, supporting long-term profitability even if sales growth slows and enabling reinvestment or dividends.

Negative Factors

Revenue decline and inconsistent growth

A 3.1% revenue decline in 2026 after prior modest growth signals demand volatility or execution issues. Persistently uneven top-line growth limits scale benefits, complicates margin recovery, and makes medium‑term planning and capacity utilization less predictable.

Medinex Ltd. Business Overview & Revenue Model

Company Description

Medinex Limited, an investment holding company founded in Singapore in 2009, specializes in providing extensive professional support services, primarily catering to medical clinics across the country. The company's operations are divided into four...

Read more

Medinex Limited, an investment holding company founded in Singapore in 2009, specializes in providing extensive professional support services, primarily catering to medical clinics across the country. The company's operations are divided into four...

Medinex Ltd. Financial Statement Overview

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	12.41M	12.81M	12.58M	12.97M	11.99M
Gross Profit	9.96M	9.93M	9.68M	9.48M	8.57M
EBITDA	2.99M	3.58M	1.79M	2.88M	4.00M
Net Income	2.22M	2.83M	1.03M	1.70M	2.81M
Balance Sheet
Total Assets	19.47M	20.69M	20.50M	22.59M	22.98M
Cash, Cash Equivalents and Short-Term Investments	5.52M	5.56M	5.17M	4.15M	6.34M
Total Debt	996.00K	1.67M	2.08M	2.34M	3.10M
Total Liabilities	2.95M	3.96M	4.34M	4.81M	5.51M
Stockholders Equity	16.52M	16.72M	16.12M	17.57M	17.25M
Cash Flow
Free Cash Flow	2.55M	3.33M	2.67M	2.83M	2.63M
Operating Cash Flow	2.71M	3.35M	2.70M	3.03M	2.86M
Investing Cash Flow	670.00K	243.45K	1.66M	-2.19M	-16.91K
Financing Cash Flow	-3.41M	-3.20M	-3.33M	-3.02M	-3.16M

Medinex Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.24
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:OTX, the sentiment is Positive. The current price of 0.24 is above the 20-day moving average (MA) of 0.22, above the 50-day MA of 0.23, and above the 200-day MA of 0.23, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 59.72 is Neutral, neither overbought nor oversold. The STOCH value of 41.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:OTX.

Medinex Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OTX	70 Outperform	S$30.95M	13.10	20.77%	7.30%	-3.11%	-21.50%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%